These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18500656)

  • 1. Carcinogenesis response modulation induced by gelonin encapsulated in liposome.
    Alam A; Nakhuru KS; Singha LI
    Mol Cell Biochem; 2008 Aug; 315(1-2):85-95. PubMed ID: 18500656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of liposome to improve encapsulation efficiency of gelonin and its effect on immunoreactivity and ribosome inactivating property.
    Alam A; Bhuri SR; Mavila AK; Singh V
    Mol Cell Biochem; 1992 Jun; 112(2):97-107. PubMed ID: 1640932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterisation of gelonin from seeds of Gelonium multiflorum.
    Singh V; Singh RC; Dubey RK; Alam A
    Indian J Biochem Biophys; 1999 Aug; 36(4):258-65. PubMed ID: 10650728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of a ribosome-inactivating protein, gelonin, purified using three different methods.
    Singh V; Kar SK
    Indian J Biochem Biophys; 1992 Feb; 29(1):31-41. PubMed ID: 1592413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thiolation of amino groups of gelonin on its protein-biosynthesis inhibitor activity.
    Singh V
    Biochem Int; 1991 Jul; 24(4):677-88. PubMed ID: 1799369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonotoxins: abrogation of ribosome inactivating property of gelonin in the disulfide linked ovine luteinizing hormone-gelonin conjugates.
    Singh V; Curtiss R
    Biochem Int; 1991 Oct; 25(3):531-6. PubMed ID: 1805797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin.
    Provoda CJ; Stier EM; Lee KD
    J Biol Chem; 2003 Sep; 278(37):35102-8. PubMed ID: 12832408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-gelonin conjugate - an inhibitor of MCF-7 cells expressing the dihydrofolate receptor.
    Badr M; Kopp C; Theison S; Meyer J; Trommer WE
    Biol Chem; 2014 Dec; 395(12):1461-6. PubMed ID: 25205711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thiolation on the immunoreactivity of the ribosome-inactivating protein gelonin.
    Singh V; Sairam MR
    Biochem J; 1989 Oct; 263(2):417-23. PubMed ID: 2597114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome immune lysis assay (LILA) for gelonin.
    Paul A; Madan S; Vasandani VM; Ghosh PC; Bachhawat BK
    J Immunol Methods; 1992 Apr; 148(1-2):151-8. PubMed ID: 1564325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the contentious sequence and glycosylation motif of the ribosome inactivating plant protein gelonin.
    Daubenfeld T; Hossann M; Trommer WE; Niedner-Schatteburg G
    Biochem Biophys Res Commun; 2005 Aug; 333(3):984-9. PubMed ID: 15967415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and toxicity of murine monoclonal antibodies and of gelonin conjugates of these antibodies.
    Scott CF; Lambert JM; Goldmacher VS; Blatter WA; Sobel R; Schlossman SF; Benacerraf B
    Int J Immunopharmacol; 1987; 9(2):211-25. PubMed ID: 3495503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gelonin-containing immunotoxin directed against human breast carcinoma.
    Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR
    Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-mediated delivery of ribosome inactivating proteins to cells in vitro.
    McIntosh DP; Heath TD
    Biochim Biophys Acta; 1982 Sep; 690(2):224-30. PubMed ID: 6982072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
    Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
    Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular tumor targeting of gelonin by fusion with F3 peptide.
    Ham SH; Min KA; Shin MC
    Acta Pharmacol Sin; 2017 Jun; 38(6):897-906. PubMed ID: 28414205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem-multimeric F3-gelonin fusion toxins for enhanced anti-cancer activity for prostate cancer treatment.
    Shin MC; Min KA; Cheong H; Moon C; Huang Y; He H; Yang VC
    Int J Pharm; 2017 May; 524(1-2):101-110. PubMed ID: 28359823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a novel type i ribosome inactivating protein, pachyerosin, from Pachyrhizus erosus seeds, and preparation of its immunotoxin against human hepatoma cells.
    Guo JL; Cheng YL; Qiu Y; Shen CH; Yi B; Peng C
    Planta Med; 2014 Jul; 80(11):896-901. PubMed ID: 25029173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.
    Bai Y; Gou M; Yi T; Yang L; Liu L; Lin X; Su D; Wei Y; Zhao X
    Int J Med Sci; 2015; 12(5):397-406. PubMed ID: 26005374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity.
    Shin MC; Min KA; Cheong H; Moon C; Huang Y; He H; Yang VC
    Pharm Res; 2016 Sep; 33(9):2218-2228. PubMed ID: 27251414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.